Literature DB >> 6820673

Growth inhibition of Toxoplasma gondii in cell cultures treated with murine type II interferon.

T Shirahata, K Shimizu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6820673     DOI: 10.1292/jvms1939.44.865

Source DB:  PubMed          Journal:  Nihon Juigaku Zasshi        ISSN: 0021-5295


× No keyword cloud information.
  7 in total

1.  Murine gamma interferon fails to inhibit Toxoplasma gondii growth in murine fibroblasts.

Authors:  J D Schwartzman; S L Gonias; E R Pfefferkorn
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

2.  Lymphokine-induced inhibition of growth of Eimeria bovis and Eimeria papillata (Apicomplexa) in cultured bovine monocytes.

Authors:  C A Speer; D W Reduker; D E Burgess; W M Whitmire; G A Splitter
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

3.  Inhibition of growth of Toxoplasma gondii in cultured fibroblasts by human recombinant gamma interferon.

Authors:  E R Pfefferkorn; P M Guyre
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

4.  Enhanced egress of intracellular Eimeria tenella sporozoites by splenic lymphocytes from coccidian-infected chickens.

Authors:  Xiaojuan Dong; Ghada H Abdelnabi; Sung H Lee; Guangxing Li; Hong Jin; Hyun S Lillehoj; Xun Suo
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

5.  Establishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3-dioxygenase.

Authors:  A Habara-Ohkubo; T Shirahata; O Takikawa; R Yoshida
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 6.  Role of gamma interferon in Toxoplasma gondii infection.

Authors:  C S Subauste; J S Remington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

7.  Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.

Authors:  G S Yap; A Sher
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.